Bladder Cancer News - ScienceDaily
Oct 9, 2024 · Bladder Cancer News. December 9, 2024. Top Headlines . Scientists Identify Brain Cell Type as Master Controller of Urination. Dec. 3, 2024 ...
Promising Breakthrough in Bladder Cancer Treatment Unveiled ...
The treatment, known as cretostimogene grenadenorepvec, is an oncolytic immunotherapy—a virus engineered to selectively target and destroy cancer cells while boosting the immune system's response to bladder tumors. In a study involving 110 participants, nearly 75% experienced complete remission, with many remaining cancer-free for over two years.
Bladder cancer: Research is driving new treatment options ...
May 22, 2024 · Bladder cancer treatment and survival have improved drastically over the last decade. Dr. Tyson wants people with bladder cancer to know they have more options than ever before. "If you have non-muscle-invasive bladder cancer, you're unlikely to die from your disease, and it's becoming more unlikely that you will lose your bladder," he says.
New ways to treat bladder cancer improve survival and shake ...
Oct 23, 2023 · A new combination of cancer medications appears to extend overall survival in patients with advanced bladder cancer more than the chemotherapies currently used as the standard of care.. The ...
Novel oncolytic immunotherapy shows promise for patients with ...
A Mayo Clinic Comprehensive Cancer Center researcher will share findings from a late-breaking abstract at the 2024 Society of Urologic Oncology Annual Meeting in Dallas, Dec. 4–6.
Bladder cancer - Latest research and news - Nature
Dec 3, 2024 · Bladder cancer articles from across Nature Portfolio. Atom; RSS Feed; Definition. Bladder cancer is a cancer that forms in tissues of the bladder. Most bladder cancers are transitional cell ...
Padcev and Keytruda Double Bladder Cancer Survival - NCI
Nov 30, 2023 · Long-awaited improvements in bladder cancer treatment. Despite the advent of many new immunotherapies and targeted drugs for cancer in the last decade, chemotherapy regimens that include platinum drugs (e.g., cisplatin) have been the standard initial treatment for people diagnosed with advanced bladder cancer for decades.
Bladder Cancer | Oncology & Cancer News | Tumor - CURE
CURE’s bladder cancer page is a go-to resource for oncology news and updates in the world of bladder cancer. Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in bladder cancer.
Advanced Bladder Cancer Patients Could Keep Their Bladder ...
Oct 2, 2023 · Removing the bladder is currently a standard approach when cancer has invaded the muscle layer of the bladder. In a phase 2 clinical trial that was the first of its kind, doctors found that some patients could be treated with a combination of chemotherapy and immunotherapy without the need to remove their bladder.
First-in-human trial finds new bladder cancer treatment safe
Mar 14, 2024 · Advanced bladder cancer patients could keep their bladder under new treatment regime, clinical trial shows Oct 2, 2023 Intravesical gemcitabine/docetaxel as an alternative therapy for patients ...
Breakthrough in bladder cancer research - ScienceDaily
Nov 16, 2023 · Breakthrough in bladder cancer research Date: November 16, 2023 Source: Netherlands Cancer Institute Summary: For 40 years, chemotherapy has been the standard treatment for bladder cancer patients ...
Bladder Cancer News, Articles and Research - News-Medical.net
Aug 20, 2017 · In North America, bladder cancer is the fourth most common cancer in men and in the top ten for women. In the United States, approximately 70,000 patients are newly diagnosed with bladder cancer ...
Landmark studies present new era for bladder cancer treatment
Nov 16, 2023 · After 40 years of treating metastatic bladder cancer with chemotherapy as a primary treatment, scientists now present a new approach using immunotherapy combinations. The results of not just one ...
A New Hope for Hard-to-Treat Bladder Cancer Made It Through ...
1 day ago · According to a news release from Mayo, “nearly 75 percent experienced complete cancer remission, with many remaining cancer-free beyond two years.” The clinic went on to add that “most participants did not require bladder removal surgery, and the treatment was well tolerated with minimal serious side effects.”
Study finds mutations, DNA structures driving bladder cancer
Oct 11, 2024 · These findings are novel insights into bladder cancer biology and point to new therapeutic strategies for this difficult-to-treat cancer. The study, published Oct. 9 in Nature, focused on the main form of bladder cancer, urothelial carcinoma, which originates from cells that line the bladder, urethra and tubes that drain urine from the kidneys ...
Treating Bladder Cancer: Latest Advancements in Care | TIME
Jul 27, 2022 · The good news for people with bladder cancer is that each new year seems to yield meaningful strides in medical science’s ability to fight the disease. The picture now is radically changed from ...
Advances in the Treatment of Bladder, Kidney Cancer
6 days ago · Management of intermediate-risk bladder cancer is undergoing significant changes, a trend accompanied by an evolving frontier in the treatment of bacillus Calmette-Guérin (BCG) unresponsive ...
Bladder Cancer | Urology News & Expert Insights | Urology Times
The bladder cancer section is a comprehensive resource for urology news and expert insights. Read more at Urology Times.
Bladder Cancer - latest research news and features
News on bladder cancer. Date. 6 hours 12 hours 1 day 3 days all. Rank. Last day 1 week 1 month all. ... Bladder cancer refers to any of several types of malignant growths of the urinary bladder ...
No Benefit for Extended Lymph Node Surgery in MIBC
Nov 6, 2024 · The SWOG Cancer Research Network conducted the study. Both trials suggest that standard lymph node surgery, when done well, is sufficient for most patients, noted Ashish Kamat, M.D., director of bladder cancer research at the University of Texas MD Anderson Cancer Center and one of the surgeons who enrolled study participants.